208 related articles for article (PubMed ID: 19375465)
1. Involvement of oxidative pathways in cytokine-induced secretory phospholipase A2-IIA in astrocytes.
Jensen MD; Sheng W; Simonyi A; Johnson GS; Sun AY; Sun GY
Neurochem Int; 2009 Nov; 55(6):362-8. PubMed ID: 19375465
[TBL] [Abstract][Full Text] [Related]
2. AMPK Signaling Involvement for the Repression of the IL-1β-Induced Group IIA Secretory Phospholipase A2 Expression in VSMCs.
El Hadri K; Denoyelle C; Ravaux L; Viollet B; Foretz M; Friguet B; Rouis M; Raymondjean M
PLoS One; 2015; 10(7):e0132498. PubMed ID: 26162096
[TBL] [Abstract][Full Text] [Related]
3. Pro-inflammatory cytokines and lipopolysaccharide induce changes in cell morphology, and upregulation of ERK1/2, iNOS and sPLA₂-IIA expression in astrocytes and microglia.
Sheng W; Zong Y; Mohammad A; Ajit D; Cui J; Han D; Hamilton JL; Simonyi A; Sun AY; Gu Z; Hong JS; Weisman GA; Sun GY
J Neuroinflammation; 2011 Sep; 8():121. PubMed ID: 21943492
[TBL] [Abstract][Full Text] [Related]
4. Induction of secretory phospholipase A2 in reactive astrocytes in response to transient focal cerebral ischemia in the rat brain.
Lin TN; Wang Q; Simonyi A; Chen JJ; Cheung WM; He YY; Xu J; Sun AY; Hsu CY; Sun GY
J Neurochem; 2004 Aug; 90(3):637-45. PubMed ID: 15255941
[TBL] [Abstract][Full Text] [Related]
5. Modulation of cytokine-induced expression of secretory phospholipase A2-type IIA by protein kinase C in rat renal mesangial cells.
Scholz K; Vlachojannis GJ; Spitzer S; Schini-Kerth V; Van Den Bosch H; Kaszkin M; Pfeilschifter J
Biochem Pharmacol; 1999 Dec; 58(11):1751-8. PubMed ID: 10571249
[TBL] [Abstract][Full Text] [Related]
6. Redox regulation of glial inflammatory response to lipopolysaccharide and interferongamma.
Pawate S; Shen Q; Fan F; Bhat NR
J Neurosci Res; 2004 Aug; 77(4):540-51. PubMed ID: 15264224
[TBL] [Abstract][Full Text] [Related]
7. Search of factors that intermediate cytokine-induced group IIA phospholipase A2 expression through the cytosolic phospholipase A2- and 12/15-lipoxygenase-dependent pathway.
Kuwata H; Nonaka T; Murakami M; Kudo I
J Biol Chem; 2005 Jul; 280(27):25830-9. PubMed ID: 15878884
[TBL] [Abstract][Full Text] [Related]
8. Astrocytes regulate α-secretase-cleaved soluble amyloid precursor protein secretion in neuronal cells: Involvement of group IIA secretory phospholipase A2.
Yang X; Sheng W; Ridgley DM; Haidekker MA; Sun GY; Lee JC
Neuroscience; 2015 Aug; 300():508-17. PubMed ID: 26037803
[TBL] [Abstract][Full Text] [Related]
9. Secretory phospholipase A2 IIA is up-regulated by TNF-alpha and IL-1alpha/beta after transient focal cerebral ischemia in rat.
Adibhatla RM; Hatcher JF
Brain Res; 2007 Feb; 1134(1):199-205. PubMed ID: 17204250
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of interleukin-1beta-induced group IIA secretory phospholipase A2 expression by peroxisome proliferator-activated receptors (PPARs) in rat vascular smooth muscle cells: cooperation between PPARbeta and the proto-oncogene BCL-6.
Ravaux L; Denoyelle C; Monne C; Limon I; Raymondjean M; El Hadri K
Mol Cell Biol; 2007 Dec; 27(23):8374-87. PubMed ID: 17908795
[TBL] [Abstract][Full Text] [Related]
11. Enhanced expression of group IIA secreted phospholipase A2 by elevated glucose levels in cytokine-stimulated rat mesangial cells and in kidneys of diabetic rats.
Vlachojannis GJ; Scholz-Pedretti K; Fierlbeck W; Geiger H; Pfeilschifter J; Kaszkin M
Clin Nephrol; 2005 May; 63(5):356-67. PubMed ID: 15909595
[TBL] [Abstract][Full Text] [Related]
12. Oleanolic acid protects against cognitive decline and neuroinflammation-mediated neurotoxicity by blocking secretory phospholipase A2 IIA-activated calcium signals.
Zhang L; Xia R; Jia J; Wang L; Li K; Li Y; Zhang J
Mol Immunol; 2018 Jul; 99():95-103. PubMed ID: 29747052
[TBL] [Abstract][Full Text] [Related]
13. Secretory phospholipase A2 plays an essential role in microglial inflammatory responses to Mycobacterium tuberculosis.
Yang CS; Yuk JM; Shin DM; Kang J; Lee SJ; Jo EK
Glia; 2009 Aug; 57(10):1091-103. PubMed ID: 19115385
[TBL] [Abstract][Full Text] [Related]
14. Cytosolic phospholipase A2 is required for cytokine-induced expression of type IIA secretory phospholipase A2 that mediates optimal cyclooxygenase-2-dependent delayed prostaglandin E2 generation in rat 3Y1 fibroblasts.
Kuwata H; Nakatani Y; Murakami M; Kudo I
J Biol Chem; 1998 Jan; 273(3):1733-40. PubMed ID: 9430720
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1beta-induced substance P release from rat cultured primary afferent neurons driven by two phospholipase A2 enzymes: secretory type IIA and cytosolic type IV.
Morioka N; Takeda K; Kumagai K; Hanada T; Ikoma K; Hide I; Inoue A; Nakata Y
J Neurochem; 2002 Mar; 80(6):989-97. PubMed ID: 11953449
[TBL] [Abstract][Full Text] [Related]
16. Studies on a mechanism by which cytosolic phospholipase A2 regulates the expression and function of type IIA secretory phospholipase A2.
Kuwata H; Yamamoto S; Miyazaki Y; Shimbara S; Nakatani Y; Suzuki H; Ueda N; Yamamoto S; Murakami M; Kudo I
J Immunol; 2000 Oct; 165(7):4024-31. PubMed ID: 11034413
[TBL] [Abstract][Full Text] [Related]
17. Platelet activating factor (PAF) antagonists on cytokine induction of iNOS and sPLA2 in immortalized astrocytes (DITNC).
Wang JH; Sun GY
Neurochem Res; 2000 May; 25(5):613-9. PubMed ID: 10905622
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of secretory phospholipase A2 IIa reduces lung cancer growth in vitro and in vivo.
Yu JA; Mauchley D; Li H; Meng X; Nemenoff RA; Fullerton DA; Weyant MJ
J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1185-91. PubMed ID: 23079010
[TBL] [Abstract][Full Text] [Related]
19. Activation of p38 MAPK induced peroxynitrite generation in LPS plus IFN-gamma-stimulated rat primary astrocytes via activation of iNOS and NADPH oxidase.
Yoo BK; Choi JW; Shin CY; Jeon SJ; Park SJ; Cheong JH; Han SY; Ryu JR; Song MR; Ko KH
Neurochem Int; 2008 May; 52(6):1188-97. PubMed ID: 18289732
[TBL] [Abstract][Full Text] [Related]
20. Diphenyleneiodium chloride blocks inflammatory cytokine-induced up-regulation of group IIA phospholipase A(2) in rat mesangial cells.
Dorsam G; Taher MM; Valerie KC; Kuemmerle NB; Chan JC; Franson RC
J Pharmacol Exp Ther; 2000 Jan; 292(1):271-9. PubMed ID: 10604958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
